New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
05:46 EDTVNDAVanda Pharmaceuticals upgraded to Buy from Hold at Jefferies
Jefferies upgraded Vanda Pharmaceuticals citing positive sleep efficacy data for the company's tasimelteon drug. The firm raised its price target for shares to $6.00 from $3.50.
News For VNDA From The Last 14 Days
Check below for free stories on VNDA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
08:34 EDTVNDAVanda requests award of $539M in proceedings with Novartis
Subscribe for More Information
July 10, 2014
14:24 EDTVNDAT. Rowe Price reports 10.1% passive stake in Vanda Pharmaceuticals
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use